Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CDXS
CDXS logo

CDXS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Codexis Inc (CDXS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.630
1 Day change
7.24%
52 Week Range
3.870
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Codexis Inc (CDXS) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock's recent financial performance shows significant net income and EPS declines despite revenue growth. Insider selling has surged, and there are no significant positive trading signals or catalysts to suggest immediate upside potential. The technical indicators and options data also do not indicate a strong entry point currently.

Technical Analysis

The MACD histogram is positive but contracting, RSI is neutral at 60.63, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 1.65, with resistance at 1.853 and support at 1.448.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
10

Positive Catalysts

  • Revenue increased by 81.34% YoY in Q4 2025, and gross margin improved by 14.20% YoY to 94.75%.

Neutral/Negative Catalysts

  • Net income dropped by -192.53% YoY, and EPS fell by -184.62% YoY. Insider selling increased by 150.31% over the last month. No recent news or significant trading trends were observed.

Financial Performance

In Q4 2025, revenue grew significantly by 81.34% YoY to $38.92M, but net income declined sharply by -192.53% YoY to $9.6M. EPS dropped to 0.11, down -184.62% YoY, despite an improvement in gross margin to 94.75%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available for evaluation.

Wall Street analysts forecast CDXS stock price to rise
5 Analyst Rating
Wall Street analysts forecast CDXS stock price to rise
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 1.520
sliders
Low
2
Averages
6
High
11
Current: 1.520
sliders
Low
2
Averages
6
High
11
No data

No data

People Also Watch